Viewing Study NCT03136666


Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2026-01-02 @ 4:55 AM
Study NCT ID: NCT03136666
Status: COMPLETED
Last Update Posted: 2017-05-02
First Post: 2017-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module